CSIMarket
 
Heartsciences Inc   (NASDAQ: HSCS)
 

Heartsciences Inc's Customers Performance

HSCS



 
HSCS's Source of Revenues

List of HSCS Customers




for the same period Heartsciences Inc

List of HSCS Customers





Heartsciences Inc's Comment on Sales, Marketing and Customers



The company provides ECG testing solutions for healthcare settings, including primary care environments and large health systems in the United States and internationally. Its MyoVista Insights platform is designed for institutions without centralized ECG management infrastructure, offering a cloud-native, SaaS ECG management system to modernize ECG workflows. The MyoVista wavECG device supports this platform by facilitating point-of-care ECG acquisition and analysis. The company's market focus is on improving early identification of heart disease and addressing fragmented ECG data management within healthcare systems.


  News about Heartsciences Inc Contracts

Advancements in Cardiovascular Care HeartSciences MyoVista wavECG Promises Enhanced Efficiency

In a significant development for cardiovascular healthcare, Heart Test Laboratories, Inc., operating as HeartSciences, has announced findings that suggest its MyoVista wavECG technology has the potential to greatly improve efficiency within the cardiovascular pathway. The analysis, published by the Innovation Value Institute (IVI), emphasizes the role of artificial intelligence (AI) in enhancing electrocardiograms (ECGs or EKGs) and assisting in the earlier detection of heart disease.HeartSciences, which trades on NASDAQ under the symbols HSCS and HSCSW, positions itself at the forefront of medical technology by integrating AI within its diagnostic tools. The MyoVista wavECG device utilizes advanced algorith...




Heartsciences Inc’s Comment on Sales, Marketing and Customers


The company provides ECG testing solutions for healthcare settings, including primary care environments and large health systems in the United States and internationally. Its MyoVista Insights platform is designed for institutions without centralized ECG management infrastructure, offering a cloud-native, SaaS ECG management system to modernize ECG workflows. The MyoVista wavECG device supports this platform by facilitating point-of-care ECG acquisition and analysis. The company's market focus is on improving early identification of heart disease and addressing fragmented ECG data management within healthcare systems.








HSCS's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Heartsciences Inc 9.53 0.00 -9.04 -
SUBTOTAL 0.00 0.00 0.00 -

Sources: Heartsciences Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Heartsciences Inc’s corporate clients.
For your research, we’ve provided 9 tables on Heartsciences Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.